Manufacturer/Distributor:
Merck Canada Inc.
merck.ca
ATC Class:
J05AG: Non-nucleoside reverse transcriptase inhibitor
Notice of Compliance (yyyy/mm/dd):
Date Marketed in Canada (yyyy/mm/dd):
Presentation:
Tablet: 100 mg. DIN: 02481545
Source:
Produce monograph; letter from company